Miv Therapeutics, Inc. (IVT) Tops Q4 EPS by 5c; offers guidance
Get Alerts IVT Hot Sheet
Join SI Premium – FREE
Miv Therapeutics, Inc. (NYSE: IVT) reported Q4 EPS of $0.03, $0.05 better than the analyst estimate of ($0.02).
GUIDANCE:
Miv Therapeutics, Inc. sees FY2026 EPS of $0.16-$0.22, versus the consensus of $0.25.
For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
- UBS Upgrades Pagegroup Plc. (PAGE:LN) (MPGPY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share